as 10-29-2025 9:35am EST
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Upcoming Earnings Alert:
Get ready for potential market movements as Verastem Inc. VSTM prepares to release earnings report on 04 Nov 2025.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | NEEDHAM |
| Market Cap: | 493.6M | IPO Year: | 2012 |
| Target Price: | $13.38 | AVG Volume (30 days): | 2.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.52 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.19 - $11.24 | Next Earning Date: | 11-04-2025 |
| Revenue: | $2,137,000 | Revenue Growth: | -78.63% |
| Revenue Growth (this year): | 79.32% | Revenue Growth (next year): | 413.52% |
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Bunn Paul A. | VSTM | Director | Oct 9 '25 | Sell | $9.06 | 8,333 | $75,496.98 | 8,333 | |
| Calkins Daniel | VSTM | Chief Financial Officer | Sep 24 '25 | Sell | $9.23 | 25 | $230.75 | 109,838 | |
| Calkins Daniel | VSTM | Chief Financial Officer | Sep 22 '25 | Sell | $9.08 | 57 | $517.56 | 109,838 | |
| Gagnon Robert E. | VSTM | Director | Sep 16 '25 | Sell | $9.99 | 281 | $2,807.19 | 41,961 | |
| Stuglik Brian M | VSTM | Director | Sep 16 '25 | Sell | $9.99 | 587 | $5,864.13 | 101,739 | |
| Paterson Dan | VSTM | President and CEO | Sep 16 '25 | Sell | $9.99 | 390 | $3,896.10 | 442,117 |
VSTM Breaking Stock News: Dive into VSTM Ticker-Specific Updates for Smart Investing
Business Wire
6 days ago
Zacks
6 days ago
Business Wire
6 days ago
Simply Wall St.
8 days ago
Zacks
8 days ago
Zacks
8 days ago
MT Newswires
9 days ago
Zacks
9 days ago
The information presented on this page, "VSTM Verastem Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.